Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme

por Miehlke, Stephan, Schlag, Christoph, Lucendo, Alfredo J., Biedermann, Luc, Vaquero, Cecilio Santander, Schmoecker, Christoph, Hayat, Jamal, Hruz, Petr, Ciriza de los Rios, Constanza, Bredenoord, Albert Jan, Vieth, Michael, Schoepfer, Alain, Attwood, Stephen, Mueller, Ralph, Burrack, Sarah, Greinwald, Roland, Straumann, Alex
Publicado 2022